IDEAYA Biosciences (IDYA) Short-term Investments (2018 - 2026)

IDEAYA Biosciences (IDYA) has 9 years of Short-term Investments data on file, last reported at $513.7 million in Q1 2026.

• For the quarter ending Q1 2026, Short-term Investments fell 45.55% year-over-year to $513.7 million; the trailing twelve-month figure through Mar 2026 stood at $513.7 million (down 45.55% YoY), and the FY2025 full-year result was $526.6 million, down 11.04% from the prior year.
• Short-term Investments fell to $513.7 million in Q1 2026, from $526.6 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $943.4 million in Q1 2025 to a low of $197.3 million in Q1 2022.
• A 5-year average of $446.6 million and a median of $488.0 million in 2025 frame the typical range for Short-term Investments.
• Across the five-year window, Short-term Investments surged 116.88% in 2024 and tumbled 45.55% in 2026, its largest moves.
• Tracing IDYA's Short-term Investments over 5 years: stood at $296.2 million in 2022, then rose by 24.27% to $368.1 million in 2023, then surged by 60.81% to $591.9 million in 2024, then declined by 11.04% to $526.6 million in 2025, then decreased by 2.45% to $513.7 million in 2026.
• Business Quant data shows IDYA's Short-term Investments at $513.7 million in Q1 2026, $526.6 million in Q4 2025, and $488.0 million in Q3 2025.